相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular dynamics reveal BCR-ABL1 polymutants as a unique mechanism of resistance to PAN-BCR-ABL1 kinase inhibitor therapy
Don L. Gibbons et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells
Elisabeth Bolton-Gillespie et al.
BLOOD (2013)
Anti-oxidant vitamin E prevents accumulation of imatinib-resistant BCR-ABL1 kinase mutations in CML-CP xenografts in NSG mice
M. Nieborowska-Skorska et al.
LEUKEMIA (2013)
Proteomic Profiling Identifies Distinct Protein Patterns in Acute Myelogenous Leukemia CD34+CD38-Stem-Like Cells
Steven M. Kornblau et al.
PLOS ONE (2013)
Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors
Margaret Nieborowska-Skorska et al.
BLOOD (2012)
Chronic myeloid leukemia: mechanisms of blastic transformation
Danilo Perrotti et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors
H. Konig et al.
LEUKEMIA (2008)
Phosphatidylinositol 3-kinase p85α subunit-dependent interaction with BCR/ABL-related fusion tyrosine kinases:: Molecular mechanisms and biological consequences
SY Ren et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Chronic myeloid leukaemia: stem cell derived but progenitor cell driven
SB Marley et al.
CLINICAL SCIENCE (2005)
Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species
M Rahmani et al.
CANCER RESEARCH (2005)
Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species
JH Kim et al.
BLOOD (2005)
Evidence of ABL-kinase domain mutations in highly purified primitive stem cell populations of patients with chronic myelogenous leukemia
N Sorel et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Phosphatidylinositol-3 kinase inhibitors enhance the anti-leukemia effect of STI571
A Klejman et al.
ONCOGENE (2002)
分享论文
